The Accelerated Cure Project (ACP) is dedicated to driving innovation in MS research through a collaborative, people-centered approach. Our work is anchored by three key pillars – the ACP Repository, iConquerMS, and our inclusive engagement resources. Join us as we highlight the progress of each initiative and celebrate key achievements that showcase the strength of our unique approach to accelerating MS research. Read more…
Check out the new research projects page on the iConquerMS website! This is just one of the ways you can find understandable research results.
iConquerMS is launching CAFE-MS! This trial will seek FDA approval for a new online treatment for MS fatigue.
The RIDE Council won the Jury Special Award for outstanding achievements in patient engagement at the Made With Patient Awards!
The MREPN is compiling resources on MS minority research engagement and health equity, available soon on the ACP website!
ACP is working with DNAnexus to provide researchers worldwide with unparalleled access to data from the ACP Repository.
ACP Repository samples were used to develop Octave’s MSDA test, a key tool for measuring disease activity and treatment effectiveness.
Researching MS? Accelerate your research with samples and data from ACP. Click here to learn more!
The ECTRIMS Congress is the leading global annual event for MS research, bringing together approximately 9,000 experts from across the world to share knowledge and collaborate. ECTRIMS 2024 offered a wide range of international speakers, presentations and poster sessions. Attendees explored the latest research and treatments while networking with peers to advance MS care. Explore the main highlights from the conference! Read more…
